Members of the Steering Committee include clinicians, scientists, and public health leaders representing:
The following CDC staff members prepared this report: Food and Drug Administration Summary These recommendations replace previous recommendations for the prevention of bloodborne virus infections in hemodialysis centers and provide additional recommendations for the prevention of bacterial infections in this setting.
The recommendations in this report provide guidelines for a comprehensive infection control program that includes a infection control practices specifically designed for the hemodialysis setting, including routine serologic testing and immunization; b surveillance; and c training and education.
Implementation of this program in hemodialysis centers will reduce opportunities for patient-to-patient transmission of infectious agents, directly or indirectly via contaminated devices, equipment and supplies, environmental surfaces, or hands of personnel. Based on available knowledge, these recommendations were developed by CDC after consultation with staff members from other federal agencies and specialists in the field who met in Atlanta on October They are summarized in the Recommendations section.
This report is intended to serve as a resource for health-care professionals, public health officials, and organizations involved in the care of patients receiving hemodialysis. Chronic hemodialysis patients are at high risk for infection because the process of hemodialysis requires vascular access for prolonged periods.
In an environment where multiple patients receive dialysis concurrently, repeated opportunities exist for person-to-person transmission of infectious agents, directly or indirectly via contaminated devices, equipment and supplies, environmental surfaces, or hands of personnel.
Furthermore, hemodialysis patients are immunosuppressed 2which increases their susceptibility to infection, and they require frequent hospitalizations and surgery, which increases their opportunities for exposure to nosocomial infections. Historically, surveillance for infections associated with chronic hemodialysis focused on viral hepatitis, particularly hepatitis B virus HBV infection.
5 The behaviors of health care providers and their interactions with the health care system also influence the rate Roadmap to Elimination contains strategies on preventing HAIs in non-acute care hospital settings. Dec 08, · CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.
Am J Infect Control. Jun. 36(5) [Medline].
1 | P a g e Evidence of hand hygiene to reduce transmission and infections by multi-drug resistant organisms in health-care settings INTRODUCTION. The term nosocomial infection encompasses a narrower spectrum.
Nosocomial infections are HAIs acquired in an acute-care setting that were neither present nor incubating at the time of admission. Based on data for , 5 to 10% of patients admitted to acute-care hospitals or approximately 2 million patients per year in the United States acquire a .
Tracking Infections in Acute Care Hospitals/Facilities. Recommend on Facebook Tweet Share Compartir. NHSN is the HAI surveillance gold standard. The system (and its predecessors) started years ago helping a few hundred healthcare facilities; today, more than 17, healthcare facilities use NHSN as the cornerstone of their HAI elimination.